The primary objectives of this trial are to evaluate the safety and tolerability and to determine the maximum tolerated dose (MTD) or recommended Phase 2 dose …

ANCA-Associated Vasculitis (AAV)Idiopathic Inflammatory Myositis (IIM)Rheumatoid Arthritis (RA)+2 more

~Estimated

~$10 – $8,750

Fate TherapeuticsNCT07800871

Phase 1

Descartes-08 for Children, Adolescents and Young Adults With Childhood-onset Systemic Lupus Erythematosus, ANCA-associated Vasculitis, Juvenile Myasthenia Gravis, and Juvenile Dermatomyositis

Safety, tolerability and efficacy of Descarte-08 in children, adolescents and young adults with childhood-onset systemic lupus erythematosus, ANCA-associated v…

Childhood-onset Systemic Lupus ErythematousANCA-Associated Vasculitis (AAV)Juvenile Myasthenia Gravis+1 more

~Estimated

~$10 – $8,750

Cartesian TherapeuticsNCT07089121